Brief: Nanexa Receives Japanese Patent Approval
Sept 22 (Reuters) - Nanexa AB NANEXA.ST: NANEXA RECEIVES JAPANESE PATENT APPROVAL FOR SPECIFIC PHARMASHELL STRUCTURE KEY PATENT APPLICATION HAS BEEN GRANTED IN JAPAN AND BEEN GIVEN PATENT NUMBER JP7733651B2 PATENT IS EXPECTED TO LAST UNTIL AT LEAST DECEMBER 2039. Source text: ID:nMFN5sp0G7 Further company coverage: NANEXA.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Nanexa AB
See all newsNanexa shares soar on €1.17 billion Novo Nordisk deal for injection technology
Brief: Nanexa And Novo Enter Global License, Collaboration Deal
Brief: Forge Nano And Nanexa To Develop Gmp-Compatible Ald Manufacturing Equipment
Brief: Nanexa Q2 Revenue Amounted To SEK 1.7 Million
Sweden's Nanexa Q1 revenue falls, loss widens